Since then, several authors have studied LASP1 expression, at the mRNA or protein level, in different cancer types [2,3,4,5,6,7,8], reporting that its overexpression is inversely correlated with poor prognosis in breast and prostate cancer, medulloblastoma and hepatocellular carcinoma (HCC). Here, LASP1 is linked to cancer.